Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1678

Sort by

Sort Order Select

Journal Articles

FXII inhibition: multipronged benefits

Helen Philippou

Blood (2021) 138 (2): 107–109.

https://doi.org/10.1182/blood.2021011032

Published: 2021

Journal Articles

FV/FVa revealed

Josefin Ahnström

Blood (2021) 137 (22): 3011–3013.

https://doi.org/10.1182/blood.2021011573

Published: 2021

Journal Articles

SPARCing the clot

Bram van Os, Esther Lutgens

Blood (2021) 137 (11): 1441–1442.

https://doi.org/10.1182/blood.2020009204

Published: 2021

Journal Articles

Anticoagulant activity of edoxaban in patients with cirrhosis

Sarah Bos, Tim Schreuder, Hans Blokzijl, Jelle Adelmeijer, Ton Lisman, Pieter W. Kamphuisen

Blood (2020) 136 (13): 1561–1564.

https://doi.org/10.1182/blood.2020005319

Published: 2020

Journal Articles

Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis

Blood (2020) 135 (16): 1377–1385.

https://doi.org/10.1182/blood.2019004114

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Diagnosing HIT: the need for speed

Adam Cuker, Douglas B. Cines

Blood (2020) 135 (14): 1082–1083.

https://doi.org/10.1182/blood.2019004676

Published: 2020

Journal Articles

How I treat obese patients with oral anticoagulants

Tzu-Fei Wang, Marc Carrier

Blood (2020) 135 (12): 904–911.

https://doi.org/10.1182/blood.2019003528

Published: 2020

Journal Articles

How I assess and manage the risk of bleeding in patients treated for venous thromboembolism

Frederikus A. Klok, Menno V. Huisman

Blood (2020) 135 (10): 724–734.

https://doi.org/10.1182/blood.2019001605

Published: 2020

Journal Articles

The phase 3 pediatric anticoagulant era

Neil A. Goldenberg, Brian R. Branchford

Blood (2020) 135 (7): 459–460.

https://doi.org/10.1182/blood.2019004340

Published: 2020

Journal Articles

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Jason Moran, Kenneth A. Bauer

Blood (2020) 135 (5): 344–350.

https://doi.org/10.1182/blood.2019000917

Published: 2020

Journal Articles

Novel antithrombotic strategies for treatment of venous thromboembolism

Jeffrey I. Weitz, Noel C. Chan

Blood (2020) 135 (5): 351–359.

https://doi.org/10.1182/blood.2019000919

Published: 2020

Journal Articles

Acute treatment of venous thromboembolism

Cecilia Becattini, Giancarlo Agnelli

Blood (2020) 135 (5): 305–316.

https://doi.org/10.1182/blood.2019001881

Published: 2020

Journal Articles

Long-term treatment of venous thromboembolism

Clive Kearon, Susan R. Kahn

Blood (2020) 135 (5): 317–325.

https://doi.org/10.1182/blood.2019002364

Published: 2020

Journal Articles

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Yanyan Shao, Wenman Wu, Guanqun Xu, Xuefeng Wang, Qiulan Ding

Blood (2019) 134 (20): 1745–1754.

https://doi.org/10.1182/blood.2018886069

Published: 2019

Includes: Supplemental data

Journal Articles

Low FV beneficial in FVFVIII deficiency?

Björn Dahlbäck

Blood (2019) 134 (20): 1686–1688.

https://doi.org/10.1182/blood.2019003243

Published: 2019

Journal Articles

Treatment with the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrates High Overall Response Rate and Durable Responses in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Updated Results from a Phase 1/2 Trial

Gavin Cull, MB, BS, FRACP, FRCPA, David Simpson, MBChB, FRACP, FRCPA, Stephen Opat, Jan A. Burger, MD PhD, Judith Trotman, MBChB, FRACP, FRCPA, Paula Marlton, MBBS (Hons), FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA, Javier Munoz, MD MS, FACP, John F. Seymour, MBBS, PhD FRACP, Andrew W. Roberts, MBBS, PhD, Ken Wu, PhD, Siminder Atwal, PhD, William Novotny, MD, Jane Huang, MD, Constantine S. Tam, MBBS, MD

Blood (2019) 134 (Supplement_1): 500.

https://doi.org/10.1182/blood-2019-125483

Published: 2019

Journal Articles

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

XI WU, M.S., Dai Jing, Fang Li, PhD, Qin Xu, PhD, Changming Chen, Qiulan Ding, Xuefeng Wang, MD, Wenman WU, MD

Blood (2019) 134 (Supplement_1): 442.

https://doi.org/10.1182/blood-2019-127694

Published: 2019

Journal Articles

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Megan C. Brown, MD, Michael H. White, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 627.

https://doi.org/10.1182/blood-2019-127258

Published: 2019

Journal Articles

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Yongzhi Qiu, PhD, Yumiko Sakurai, MSc, Wilbur A. Lam, MD PhD

Blood (2019) 134 (Supplement_1): 441.

https://doi.org/10.1182/blood-2019-128718

Published: 2019

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

NARROW

FXII inhibition: multipronged benefits

FV/FVa revealed

SPARCing the clot

Anticoagulant activity of edoxaban in patients with cirrhosis

Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis

Diagnosing HIT: the need for speed

How I treat obese patients with oral anticoagulants

How I assess and manage the risk of bleeding in patients treated for venous thromboembolism

The phase 3 pediatric anticoagulant era

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Novel antithrombotic strategies for treatment of venous thromboembolism

Acute treatment of venous thromboembolism

Long-term treatment of venous thromboembolism

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Low FV beneficial in FVFVIII deficiency?

Treatment with the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrates High Overall Response Rate and Durable Responses in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Updated Results from a Phase 1/2 Trial

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only